2 completed, 2 unknown, 1 recruiting, 1 terminated. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Keio University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients Dialysate fluid, Filtration replacement fluid - Acute Kidney Injury Requiring Continuous Renal Replacement Therapy | Phase 2 / Phase 3 | Recruiting | Jikei University School of Medicine | 400 | 2023-10-30 | 2026-08-05 |
| Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial) Satralizumab (Genetical Recombination) - Pulmonary Arterial Hypertension | Phase 2 | Completed | International University of Health and Welfare | 20 | 2022-07-12 | 2026-07-15 |
| Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma Pembrolizumab and Imatinib mesylate - Melanoma | Phase 1 / Phase 2 | Unknown | Keio University | 22 | 2020-09-14 | 2023-10-03 |
| Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel FLOT therapy - Esophageal Squamous Cell Carcinoma | Phase 2 | Unknown | Keio University | 60 | 2020-06-25 | 2022-08-17 |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies Cord blood transplantation, TBI, cyclophosphamide - Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Completed | Keio University | 33 | 2006-01-01 | 2012-04-06 |
| Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma Rituximab, Etoposide, Methylprednisolone, Cytarabine, Cisplatin - Lymphoma, Non-Hodgkin | Phase 2 | Terminated | Keio University | 5 | 2005-08-01 | 2007-11-20 |
Esophageal Squamous Cell Carcinoma (1) · Hematologic Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Pulmonary Arterial Hypertension (1)
Cytarabine (2) · Cisplatin (1) · Cord Blood Stem Cell Transplantation (1) · Cyclophosphamide (1) · Etoposide (1) · Imatinib Mesylate (1) · Methylprednisolone (1) · Rituximab (1) · pembrolizumab (1) · satralizumab (1)
Japan (6)
Hisashi Sakamaki, M.D., Ph.D. (1) · Norihiro Awaya, MD, PhD (1) · Takeru Funakoshi, MD (1) · Tomoko Fujii, MD,PhD (1) · Yuichi Tamura (1)